Eplerenone tablets bulk supplier for pharma manufacturers

Eplerenone Tablets 25 mg and 50 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 25 mg and 50 mg

Reference Brands: Inspra(US & EU)

Eplerenone is a selective mineralocorticoid receptor antagonist that blocks aldosterone, reducing sodium retention and counteracting heart remodeling. It effectively lowers blood pressure, decreases hospitalization in heart failure, and improves cardiac function. Benefits include improved survival, reduced fluid retention, and better cardiovascular outcomes.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Eplerenone Tablets? List it or send an offer →

Product Description: Eplerenone tablets, marketed as Inspra, are approved in the US by the FDA and in the EU via EMA for managing hypertension and heart failure. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical and quality information, while the EMA ensures compliance with regional safety and manufacturing standards. Proper regional compliance supports timely approval, safe use, and global availability of eplerenone tablets, helping improve cardiovascular health worldwide and supporting effective management of hypertension and heart failure.

Eplerenone Tablets — third party manufacturing & bulk supply

Eplerenone Tablets 25 mg and 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Eplerenone Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Eplerenone Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Eplerenone Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Eplerenone tablets is listed as Tablet in 25 mg and 50 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Eplerenone tablets is referenced against Inspra(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.